Biotech & Bioprocessing

Vascularized Liver Organoids Revolutionize Regenerative Medicine
Biotech & Bioprocessing Vascularized Liver Organoids Revolutionize Regenerative Medicine

The world of regenerative medicine has been animated by a remarkable breakthrough in tissue engineering, involving the creation of liver organoids capable of developing their own vascular systems. Emerging from a collaborative effort between scientists at Cincinnati Children's Hospital Medical

How Can Custom Biosecurity Plans Protect Cattle Operations?
Biotech & Bioprocessing How Can Custom Biosecurity Plans Protect Cattle Operations?

In the evolving landscape of cattle agricultural enterprises, ensuring livestock health through tailored biosecurity strategies is a vital component of successful operations. The diversity of cattle operations leads to varying levels of risk and distinct control points, highlighting the importance

Veranova Expands Devens Facility, Boosts ADC Development
Biotech & Bioprocessing Veranova Expands Devens Facility, Boosts ADC Development

Veranova has announced a major expansion of its Devens, Massachusetts facility, marking a significant step forward in the development and manufacturing of Antibody-Drug Conjugates (ADCs) and highly potent compounds. The company is investing $50 million to extend the facility by 9,000 square feet,

Mitochondrial Base Editing: A Breakthrough in Gene Therapy
Biotech & Bioprocessing Mitochondrial Base Editing: A Breakthrough in Gene Therapy

The ongoing quest to treat mitochondrial diseases has achieved a revolutionary stride, enhancing possibilities within gene therapy landscapes through mitochondrial base editing (mtBE). Recent innovations by scientists at the University Medical Center Utrecht signify a substantial advancement in

Australia Debates Deregulation of GM Foods Amid Transparency Concerns
Biotech & Bioprocessing Australia Debates Deregulation of GM Foods Amid Transparency Concerns

The recent proposal by Food Standards Australia and New Zealand (FSANZ) has sparked a heated debate regarding the potential deregulation of genetically modified (GM) foods, positioning Australia at a critical juncture in food regulation. The proposal, known as Proposal P1055, has drawn significant

Synthetic Biology Market to Reach $40B by 2032 Driven by Innovation
Biotech & Bioprocessing Synthetic Biology Market to Reach $40B by 2032 Driven by Innovation

The synthetic biology market is on an unprecedented trajectory, projected to swell to $40 billion by 2032. This substantial growth reflects synthetic biology's rising influence across numerous critical sectors, including healthcare, agriculture, industrial biotechnology, and environmental

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later